 |
|
 |
 |
 |
Reagents for DPP IV Research
 | Dipeptidyl peptidase IV (DPP IV), a widely distributed, multifunctional transmembrane serine protease, has attracted considerable interest in recent times. It modulates the activity of several peptide hormones by cleaving Xaa-Pro or Xaa-Ala from their NH2-terminal. DPP IV functions as a dimer and each monomeric subunit has an a/b hydrolase domain and an eight-bladed b-propeller domain. Both these domains participate in inhibitor binding at the active site. Of considerable interest is the cleavage of glucagon-like peptide-1 (GLP-1) by DPP IV.
GLP-1 is shown to be important in maintaining glucose homeostasis. It blocks glucagon secretion, delays gastric emptying, and stimulates insulin biosynthesis. GLP-1 has been under consideration as an alternate treatment for type II diabetes. However, its short half-life (<1 min) severely limits its use as a treatment option. To overcome this difficulty, inhibition DPP IV has been proposed as a viable option and DPP IV inhibitors are shown to improve glucose tolerance in animal models of type II diabetes.
| | Assay Kits |
|
|
|
| InnoZyme™ DPP IV Activity Assay Kit NEW! |
CBA097 |
| InnoZyme™ DPP IV Immunocapture Activity Assay NEW! |
CBA085 |
|
| | Enzymes |
|
|
|
| Dipeptidyl Peptidase IV (CD26), Porcine Kidney |
317640 |
| Dipeptidylpeptidase IV, Human Placenta |
317630 |
| Dipeptidylpeptidase IV, Human, Recombinant, S. frugiperda |
317639 |
|
| | Antibody |
|
|
|
|
|
| Anti-Dipeptidylpeptidase IV Rabbit pAb |
FS, IB, IP |
human |
IM1004 |
|
| | Substrate |
|
|
|
| Dipeptidylpeptidase IV Substrate I, Fluorogenic |
125510 |
|
| | Inhibitor |
|
|
|
| Dipeptidylpeptidase IV Inhibitor I |
416200 |
|
|
 |
 |
|
|